Literature DB >> 2037800

Evolution of the placental barrier to fetal infection by murine enteroviruses.

M J Abzug1, H A Rotbart, S A Magliato, M J Levin.   

Abstract

A murine model that demonstrated a placental barrier to fetal enterovirus infection in late pregnancy was extended to middle and early gestation. Inoculation with Theiler's murine encephalomyelitis virus (TMEV) in middle and early gestation infected 73% and 90% of placentas and 7% and 78% of fetuses, respectively. In situ hybridization (ISH) of tissues obtained after middle-gestation inoculation revealed TMEV in the placental decidua and spongiotrophoblast layers but generally not in the labyrinth (the layer adjacent to the fetus) or fetus (similar to late gestation). In contrast, ISH of placentas harvested after early-gestation inoculation identified TMEV predominantly in the labyrinth, in which vasculature was often replaced by hyalinized hemorrhagic tissue and small cell infiltrates; fetuses contained virus in heart, pericardium, great vessels, lung, pleura, brain, and liver. The placental barrier to enterovirus transmission appears to develop between early and middle gestation. Enterovirus infection before this time may induce placental damage, fetal infection, or both.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2037800     DOI: 10.1093/infdis/163.6.1336

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  2 in total

1.  Kinetics of infection and effects on placental cell populations in a murine model of Chlamydia psittaci-induced abortion.

Authors:  A J Buendía; J Sánchez; M C Martínez; P Cámara; J A Navarro; A Rodolakis; J Salinas
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

2.  Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor.

Authors:  Ingrid Cardenas; Robert E Means; Paulomi Aldo; Kaori Koga; Sabine M Lang; Carmen J Booth; Carmen Booth; Alejandro Manzur; Enrique Oyarzun; Roberto Romero; Gil Mor
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.